| Lithium Carbonate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Lithium Carbonate 300 mg | tablet | oral | 1.0 each | OTC |
| Lithium Carbonate 150 mg | capsule | oral | 1.0 each | OTC |
| Lithium Carbonate 600 mg | capsule | oral | 1.0 each | OTC |
| Lithium Carbonate 300 mg | capsule | oral | 1.0 each | OTC |
| Lithium Carbonate 450 mg | tablet, extended release | oral | 1.0 each | OTC |
| Lithium Carbonate 300 mg | tablet, extended release | oral | 1.0 each | OTC |
| Lithium Carbonate - | powder | compounding | 100.0 gram(s) | OTC |
Posted by sparkplug 2 months ago
I started taking lithium Carbonate about a year ago. I didn't care about side effects and i didn't think that any would happ...
Posted by kguthrie 2 months ago
I was on a maximum of 900 mg's a day and my last dosage was at 300 mg's a day. Lithium was great for me in the winter when m...
Posted by ohla 7 months ago
I'm also have lithium carbonate 600 mg daily, separate in the morning 300 mg and evening 300 mg. After 1 months I also have p...
Lithium could treat cannabis withdrawal: study - ABC Online
A new study has found that lithium carbonate may help long-term cannabis users quit the drug. The preliminary study showed short-term use of lithium ...
Thu Mar 06 20:24:29 -0500 2008
Black Pearl Signs Letter Agreement to Acquire Quebec Lithium - Market Wire (press release)
... chemical grade spodumene concentrates, lithium carbonate, lithium hydroxide monohydrate as well as a small quantity of lithium chloride and feldspar. ...
Thu Mar 06 10:57:44 -0500 2008
Noven Announces 2007 Earnings Release Date - Trading Markets (press release)
... offered through Noven's psychiatry/CNS marketing and sales organization consist of Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...
Thu Mar 06 17:06:46 -0500 2008
lithium carbonate - The carbonate salt of lithium, a monovalent cation with antimanic activity. Lithium carbonate interferes with transmembrane sodium exchange in nerve cells by affecting sodium, potassium-stimulated adenosine triphosphatase (Na+, K+-ATPase); altering the release of neurotransmitters; reducing cyclic adenosine monophosphate (cAMP) concentrations and modulating cAMP second-messenger processes; and suppressing signal transduction pathways through the depletion of intracellular inositol and inhibition of the enzyme, glycogen synthase-kinase-3 (GSK-3). The exact mechanism through which lithium carbonate exerts its mood-stabilizing effect is not fully known.